{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:05:06Z","timestamp":1778742306072,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008117","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T16:21:01Z","timestamp":1506529261000},"page":"e8117","source":"Crossref","is-referenced-by-count":16,"title":["Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient"],"prefix":"10.1097","volume":"96","author":[{"given":"Carlo Ignazio","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ressico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Valsesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"D\u2019Innella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Ballabio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-30-20210309","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-200002001-00001","article-title":"Comprehensive review of the psychiatric uses of valproate","volume":"20","author":"Davis","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R2-30-20210309","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/jnp.12.3.395","article-title":"Agitated symptom response to divalproex following acute brain injury","volume":"12","author":"Chatham Showalter","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R3-30-20210309","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/026990597123791","article-title":"Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury","volume":"11","author":"Wroblewski","year":"1997","journal-title":"Brain Inj"},{"key":"R4-30-20210309","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4088\/JCP.v61n0207","article-title":"Use of sodium valproate in violent and aggressive behaviors: a critical review","volume":"61","author":"Lindenmayer","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R5-30-20210309","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin Biochem"},{"key":"R6-30-20210309","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archneur.1982.00510210061016","article-title":"Asymptomatic hyperammonemia in patients receiving valproic acid","volume":"39","author":"Murphy","year":"1982","journal-title":"Arch Neurol"},{"key":"R7-30-20210309","first-page":"E","article-title":"Valproate-related hyperammonemia in older adult psychiatric inpatients.","volume":"17","author":"Adler","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"R8-30-20210309","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis"},{"key":"R9-30-20210309","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and L-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J Anal Toxicol"},{"key":"R10-30-20210309","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann Pharmacother"},{"key":"R11-30-20210309","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R12-30-20210309","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3122\/jabfm.2007.05.070062","article-title":"Valproate-associated hyperammonemic encephalopathy","volume":"20","author":"Wadzinski","year":"2007","journal-title":"J Am Board Fam Med"},{"key":"R13-30-20210309","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1213\/ANE.0b013e318228a001","article-title":"Perioperative exacerbation of valproic acid-associated hyperammonemia: a clinical and genetic analysis","volume":"113","author":"Bezinover","year":"2011","journal-title":"Anesth Analg"},{"key":"R14-30-20210309","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.41.9.1444","article-title":"Alteration of renal carnitine metabolism by anticonvulsant treatment","volume":"41","author":"Camina","year":"1991","journal-title":"Neurology"},{"key":"R15-30-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/07315724.1986.10720124","article-title":"Carnitine as an essential nutrient","volume":"5","author":"Borum","year":"1986","journal-title":"J Am Coll Nutr"},{"key":"R16-30-20210309","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity: what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care"},{"key":"R17-30-20210309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1389201033489829","article-title":"Carnitine metabolism and deficit: when supplementation is necessary?","volume":"4","author":"Evangeliou","year":"2003","journal-title":"Curr Pharm Biotechnol"},{"key":"R18-30-20210309","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"key":"R19-30-20210309","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/NDT.S44282","article-title":"Mitochondrial dysfunction, oxidative stress, and major depressive disorder","volume":"9","author":"Tobe","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R20-30-20210309","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ajmg.b.32086","article-title":"The mitochondrial genome and psychiatric illness","volume":"159B","author":"Anglin","year":"2012","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R21-30-20210309","first-page":"79","article-title":"Acetyl-L-carnitine for depression and mood disorders.","volume":"73-","author":"Fernandes","year":"2014","journal-title":"J IHP"},{"key":"R22-30-20210309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2146\/ajhp110049","article-title":"Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy","volume":"69","author":"Mock","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"R23-30-20210309","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/epi.12125","article-title":"Risk factors for hyperammonemia in pediatric patients with epilepsy","volume":"54","author":"Yamamoto","year":"2013","journal-title":"Epilepsia"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:34:25Z","timestamp":1620959665000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709290-00030"}},"subtitle":["Essential review of the literature and case report"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":23,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008117","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}